RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
ARMD Channel

subscribe to ARMD newsletter
Latest Research : Ophthalmology : Retina : ARMD

   EMAIL   |   PRINT
Gene variant increases risk of age-related macular degeneration

Mar 11, 2005 - 2:04:00 AM
"Macular degeneration is an important cause of blindness and loss of independence in the elderly. This gene opens the door to a whole new understanding of the factors that contribute to this disease.

[RxPG] Researchers at Duke University Medical Center and Vanderbilt University Medical Center have pinpointed the first major gene that determines an individual's risk for developing age-related macular degeneration (AMD). The chronic, progressive disease -- which affects as many as 15 million people in the United States -- is the leading cause of visual impairment and legal blindness in the elderly.

A common variant of the gene, called complement factor H (CFH), explains approximately 43 percent of the risk of AMD among older adults, the researchers estimated. The team identified the disease-related gene after screening 182 families affected by AMD and 495 other individuals with the condition.

The researchers will report their findings in a forthcoming issue of Science (published online March 10, 2005, in Science Express).

The genetic advance sheds light on the mechanisms underlying the disease and could lead to new avenues for treatment, the researchers said. The finding might also yield methods for identifying those patients at the greatest risk for developing the condition before symptoms arise, when therapies and changes in lifestyle might be most effective in slowing the disease progression.

"Macular degeneration is an important cause of blindness and loss of independence in the elderly," said Margaret Pericak-Vance, Ph.D., director of the Duke Center for Human Genetics and senior author of the report. "This gene opens the door to a whole new understanding of the factors that contribute to this disease.

"The finding may ultimately lead to new methods for identifying those at high risk for macular degeneration and suggests new pathways for drug development," she added.

AMD causes progressive impairment of central vision, and is the most common cause of legal blindness in Americans over the age of 55. The disease causes damage to the retina, a thin layer of nervous tissue that lines the inside of the eye. The primary site of damage occurs in the central retina, a portion called the macula.

The retina functions like film in a camera, explained ophthalmologist Eric Postel, M.D., of the Duke University Eye Center. Without proper retinal function, images cannot be captured and sent to the brain. The macula is critical for fine, detailed vision. In patients with severe AMD, progressive blurring and loss of central vision due to damage of the macula may leave people unable to perform everyday activities such as driving, reading, writing checks and recognizing faces, he said.

"Fifteen million people in the United States have AMD and 1.5 million have the most severe form," said Postel, the head clinician on the study. "By the year 2030, as the baby boomer generation ages, the number of people with AMD is expected to double."

AMD exists in two forms: the "dry" form and more severe "wet" form. In the dry form, degeneration of the macula can cause slow, progressive vision loss over the course of months to years. While there is no cure, vitamin supplements have been shown to slow the disease in some individuals with this milder form.

In ten percent of patients, the disease progresses to the wet form in which abnormal blood vessels under the macula leak blood and fluid causing rapid damage and a precipitous loss of vision. Patients with wet AMD can receive several treatments to prevent further vision loss -- including laser surgery and recently approved injections of a drug into the eye.

However, available therapies usually can only stall the disease progression, Postel said. None effectively reverse the course of the disease.

While the underlying causes of AMD had remained largely unknown, risk factors include age, smoking, high blood pressure, obesity and diet, said Pericak-Vance. In addition to such environmental factors, evidence from family and twin studies had indicated a significant genetic contribution to the disease, she added.

Earlier studies by the Duke and Vanderbilt teams and others had linked AMD risk to a particular region on chromosome 1. To identify the gene responsible, the researchers examined two independent data sets: the first contained 182 families including members with and without AMD and the second contained 495 individuals with AMD and 185 unrelated individuals not affected by the disease.

The researchers zeroed in on a smaller region of chromosome 1 with a strong association to the disease in both data sets. Further DNA sequencing of the CFH gene that is within that region revealed that individuals with one or more copies of a particular gene variant were more likely to have AMD compared to those with other versions of the gene, they reported. When the researchers restricted the analysis to individuals with the more severe, wet form of AMD, the association between the gene variant and the disease became even stronger.

The researchers estimated that the CFH variant may be responsible for up to 43 percent of all cases of AMD.

Earlier studies had suggested that CFH may play a role in protecting blood vessels from inflammation and damage, a function which might explain its role in AMD, the researchers said.

"We knew that chronic inflammation played a role in macular degeneration, but we didn't know if that was a primary cause of the disease or a secondary symptom," said Jonathan Haines, Ph.D., of Vanderbilt Center for Human Genetics Research and first author on the report. "The finding that complement factor H is an important contributor to the disease suggests that inflammation may be a more important aspect of the disease than had previously been appreciated."

Given that the gene plays such a large role in AMD, further studies of CFH and the cellular components with which it interacts might lead to a rapid increase in understanding of the biology of the disease, the researchers added. That information, in turn, should allow scientists to advance on new treatments and preventive therapies.

Publication: March 10, 2005, in Science Express
On the web: www.dukemednews.org 

Advertise in this space for $10 per month. Contact us today.

Related ARMD News
Deficiency of the Dicer enzyme in retinal cells linked to age-related macular degeneration
Quit smoking to save your eyes
Post Menopausal Hormones - reduces risk of macular degeneration
Higher fish consumption have a reduced risk of advanced age-related macular degeneration
HTRA1 gene linked to aggressive 'wet' age-related macular degeneration
Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Hormone Therapy Does Not Affect Age-Related Vision Loss
Eating Fish Protects Against Macular Degeneration
Research Highlights Risk Factors For Age-Related Vision Loss
FDA approves ranibizumab for the treatment of wet age-related macular degeneration

Subscribe to ARMD Newsletter

Enter your email address:

 Additional information about the news article
Collaborators on the study include Michael Hauser, Silke Schmidt, William Scott, Paul Gallins, Shu Ying Kwan, Maher Noureddine and John Gilbert, of the Duke Center for Human Genetics; Lana Olson, Kylee Spencer, Nathalie Schnetz-Boutaud and Anita Agarwal, of the Vanderbilt University Medical Center. The National Eye Institute supported the work. Additional resources came from the National Institute on Aging and the National Center for Research Resources to Vanderbilt University.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)